Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)
Public ClinicalTrials.gov record NCT00562965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Randomized, Phase 3 Study Of Inotuzumab Ozogamicin (Cmc-544) Administered In Combination With Rituximab Compared To A Defined Investigator's Choice Therapy In Subjects With Relapsed Or Refractory, Cd22- Positive, Follicular B-cell Non Hodgkin's Lymphoma
Study identification
- NCT ID
- NCT00562965
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Interventions
- cyclophosphamide Drug
- dexamethasone Drug
- fludarabine Drug
- inotuzumab ozogamicin Drug
- mitoxantrone Drug
- prednisone/prednisolone Drug
- rituximab Drug
- vincristine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2007
- Primary completion
- Mar 31, 2011
- Completion
- Mar 31, 2011
- Last update posted
- Jan 8, 2018
2007 – 2011
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Facey Medical Group | Mission Hills | California | 91345 | — |
| Deaconess Clinic | Evansville | Indiana | 47713 | — |
| The Harry & Jeanette Weinberg Cancer Inst at Franklin Square | Baltimore | Maryland | 21237 | — |
| Newland Medical Associates | Novi | Michigan | 48374 | — |
| Newland Medical Associates, PC | Southfield | Michigan | 48075 | — |
| Park Nicollet Frauenshuh Cancer Center | Saint Louis Park | Minnesota | 55426 | — |
| Hematology and Oncology Associates | Columbus | Mississippi | 39706 | — |
| Hematology and Oncology Associates | Corinth | Mississippi | 38834 | — |
| Hematology and Oncology Associates at Bridgepoint | Tupelo | Mississippi | 38801 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| The Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Hematology Oncology Associates of Northern New Jersy | Morristown | New Jersey | 07960 | — |
| Advanced Oncology Associates | Armonk | New York | 10504 | — |
| Advanced Oncology Associates | New Rochelle | New York | 10801 | — |
| Marc Zimmerman, MD | Pomona | New York | 10970 | — |
| Avi Einzing, MD | The Bronx | New York | 10461 | — |
| Wenatchee Valley Medical Center | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00562965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2018 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00562965 live on ClinicalTrials.gov.